Mark Peggie
Impact in
- Immunology top 2%
- interferon and immune responses
- Immune Response and Inflammation
- Cancer Research top 2%
- NF-κB Signaling Pathways
Papers in
-
- Ubiquitin and proteasome pathways 12
- Metabolism, Diabetes, and Cancer 8
- RNA Research and Splicing 7
- Immunology 14
- interferon and immune responses 11
- Immune Response and Inflammation 8
- Co-authors
- Philip Cohen (26 shared papers)Mark Windheim (5 shared papers)Kristopher Clark (5 shared papers)Kei Sakamoto (8 shared papers)Nick Morrice (5 shared papers)J. Simon C. Arthur (5 shared papers)Nicholas A. Morrice (5 shared papers)Dario R. Alessi (4 shared papers)
- Journals
- Biochemical Journal (17 papers)Journal of Biological Chemistry (4 papers)Proceedings of the National Academy of Sciences (4 papers)The EMBO Journal (3 papers)Cellular Signalling (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark Peggie
56 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Immunology 1.4k
- Cancer Research 947
- Molecular Biology 4.0k
- Cell Biology 689
- Aging 59
Countries citing papers authored by Mark Peggie
This map shows the geographic impact of Mark Peggie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Peggie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Peggie more than expected).
Fields of papers citing papers by Mark Peggie
This network shows the impact of papers produced by Mark Peggie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Peggie. The network helps show where Mark Peggie may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Peggie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase Hit paper breakdown → | 2012 | 590 |
| 2 | 2005 | 348 | |
| 3 | 2009 | 300 | |
| 4 | 2004 | 286 | |
| 5 | 2011 | 251 | |
| 6 | 2018 | 211 | |
| 7 | 2015 | 199 | |
| 8 | 2005 | 189 | |
| 9 | 2012 | 188 | |
| 10 | 2008 | 186 | |
| 11 | 2007 | 157 | |
| 12 | 2006 | 156 | |
| 13 | 2010 | 154 | |
| 14 | 2007 | 142 | |
| 15 | 2008 | 137 | |
| 16 | 2015 | 135 | |
| 17 | 2014 | 120 | |
| 18 | 2008 | 111 | |
| 19 | 2014 | 110 | |
| 20 | 2010 | 104 |
About Mark Peggie
Mark Peggie is a scholar working on Molecular Biology, Immunology, Cancer Research, Cell Biology and Epidemiology, having authored 56 papers that have together received 5.9k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (12 papers), Ubiquitin and proteasome pathways (12 papers), interferon and immune responses (11 papers), Immune Response and Inflammation (8 papers), Metabolism, Diabetes, and Cancer (8 papers), RNA Research and Splicing (7 papers), Autophagy in Disease and Therapy (6 papers) and Pancreatic function and diabetes (6 papers). The work is most often cited by research in Immunology (1.4k citations), Cancer Research (947 citations), Molecular Biology (4.0k citations), Cell Biology (689 citations) and Aging (59 citations). Mark Peggie has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Philip Cohen, Mark Windheim, Kristopher Clark, Kei Sakamoto, Nick Morrice, J. Simon C. Arthur, Nicholas A. Morrice, Dario R. Alessi, C. James Hastie and Minghao Zhang. Their work appears in journals such as Biochemical Journal, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, The EMBO Journal and Cellular Signalling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.